Putnam Investments LLC Horizon Therapeutics Public LTD CO Transaction History

Putnam Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $14.9 Million - $21.9 Million	188,200 Added 126.73%	336,700 $26.9 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $12.8 Million - $16.3 Million	148,500 New	148,500 $15.6 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $8.35 Million - $10.5 Million	-124,584 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $1.35 Million - $1.96 Million	-24,463 Reduced 16.41%	124,584 $9.68 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $92,985 - $175,441	-3,079 Reduced 2.02%	149,047 $8.28 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $15,916 - $24,678	-640 Reduced 0.42%	152,126 $4.51 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $3.88 Million - $5.6 Million	152,766 New	152,766 $5.53 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.